Jennifer Kahn’s ‘love GMOs’ article in NYT is propaganda, not journalism
By Stacy Malkan,
U.S. Right to Know
| 07. 21. 2021
Next week in Rome, world leaders will gather to discuss how to fix the food system amid one of the worst hunger crises in recent times. According to a new United Nations report on hunger, more than 2.37 billion people did not have adequate access to food in 2020. The Covid-19 pandemic has exposed weaknesses in food systems that were already failing to meet the needs of so many people.
Rather than addressing systemic solutions for hunger and poverty, however, leaders of the upcoming UN Food Systems Summit are ignoring human rights and pushing to expand genetic engineering and commodity crop monocultures that are deepening the crises and also not feeding the world, according to hundreds of groups that are boycotting next week’s events and organizing a counter summit.
All this context is missing from a 7,000 plus word promotional article for genetically engineered foods published this week in the New York Times Magazine. Jennifer Kahn reports that, “overblown fears have turned the public against genetically modified food” even though the “potential benefits have never been greater.”...
Related Articles
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
By Simar Bajaj, The New York Times | 11.27.2025
A common cold was enough to kill Cora Oakley.
Born in Morristown, N.J., with virtually no immune system, Cora was diagnosed with severe combined immunodeficiency, a rare genetic condition that leaves the body without key white blood cells.
It’s better...
